Lamivudine (Epivir), also known as 3TC, is a nucleoside reverse transcriptase inhibitor (NRTI). It's available as Epivir to treat human immunodeficiency virus (HIV) infections and Epivir HBV to treat hepatitis B virus (HBV). Both brands and their generic formulations can be used in adults and children. But they're not interchangeable so you can't take one brand in place of another. Lamivudine (Epivir) is taken by mouth, typically once or twice daily. Some common side effects of this medication include headache, nausea, and feeling tired.
Lamivudine (Epivir) is a nucleoside reverse transcriptase inhibitor (NRTI). It blocks an enzyme (protein) found in HIV and HBV called reverse transcriptase that usually helps the virus make copies of itself. By blocking reverse transcriptase, lamivudine (Epivir) prevents HIV and HBV from making copies of itself and spreading.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effects listed were reported by people who took lamivudine (Epivir) for HIV.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Incidence not known
Black, tarry stools
bleeding gums
blood in the urine or stools
blurred vision
chills
dark urine
decreased appetite
difficulty with swallowing
dizziness
fast heartbeat
fast, shallow breathing
flushed, dry skin
fruit-like breath odor
general feeling of discomfort
general tiredness and weakness
increased hunger
increased thirst
increased urination
indigestion
light-colored stools
loss of appetite
muscle cramps, pain, stiffness, or spasms
pains in the stomach, side, or abdomen, possibly radiating to the back
pinpoint red spots on the skin
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
right upper abdominal or stomach pain and fullness
sleepiness
stomach discomfort
tightness in the chest
troubled breathing with exertion
unexplained weight loss
unusual bleeding or bruising
unusual tiredness or weakness
upper right abdominal or stomach pain
vomiting
yellow eyes or skin
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Belching
burning, tingling, numbness or pain in the hands, arms, feet, or legs
general feeling of discomfort or illness
headache
indigestion
joint pain
sensation of pins and needles
stabbing pain
stomach discomfort, upset, or pain
stuffy or runny nose
trouble sleeping
Incidence not known
Hair loss or thinning of the hair
pale skin
sweating
weight gain around your neck, upper back, breast, face, or waist
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
If you're pregnant, talk with your provider to see if lamivudine (Epivir) is a good option for you. Limited studies showed that lamivudine (Epivir) didn't raise the risk of birth defects if taken during pregnancy. In general, pregnant people who have HIV are recommended to start treatment as soon as possible to lower the risk of transferring the virus to the unborn baby. On the other hand, HBV clinical guidelines recommend treatment for only certain pregnant people with hepatitis B. If you choose to take lamivudine (Epivir) during pregnancy, you’re encouraged to enroll in the Antiretroviral Pregnancy Registry (APR). This registry collects information about your and your baby’s health during treatment with lamivudine (Epivir).
3TC is a 3 character abbreviation for lamivudine (Epivir). The shortened name is created base on the medication's chemical structure.
No, lamivudine (Epivir) isn't a cure for hepatitis B. Currently, all available medications for hepatitis B can only slow down the development of serious liver problems, including liver cancer. Medications such as lamivudine (Epivir) can lower the amount of HBV in your body, which prevents the virus from spreading.
Your provider typically prescribes lamivudine (Epivir) along with other antiretroviral medications to treat HIV. In general, the goal is to lower the amount of HIV in your body to the point where the virus is no longer detectable in lab work (undetectable viral load). Having an undetectable viral load helps keep your immune system working to protect you from infections. It also helps lower the risk of spreading HIV to others. In clinical studies that looked at how well lamivudine (Epivir) worked as part of a HIV ARV regimen, results showed that majority of people had either an undetectable viral load after about a year of treatment.
Lamivudine (Epivir) is not the same as emtricitabine (Emtriva). Although both medications have similar chemical structures, you shouldn't take both at the same time since they're doing the same thing to lower the amount of HIV in your body. They're both first-choice medications to treat HIV, but only lamivudine (Epivir) is approved to treat HBV. Talk to your provider to discuss which one is the right treatment option for you.
Lamivudine (Epivir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Lamivudine is available as both Epivir to treat HIV and Epivir HBV to treat hepatitis B virus (HBV). If you've both HIV and HBV, don't take Epivir HBV to treat your infections since the dose of the medication is too low to treat HIV. Taking the wrong dose can make it easier for HIV to change form and become harder to treat. Before you begin lamivudine (Epivir) treatment, your provider will test you for HBV and HIV. If you have both infections, your provider will make sure you're getting appropriate treatment for both HIV and HBV.
If you've both HIV and HBV, suddenly stopping lamivudine (Epivir) can also make your liver condition worse (also called an HBV flare-up). Don't stop taking lamivudine (Epivir) without talking with your provider first. Make sure to get your refills on time so that your treatment isn't interrupted. If you need to stop taking lamivudine (Epivir), your provider will follow up with you for several months after you stop treatment. They'll order blood work to check your liver for an HBV flare-up.
Lamivudine (Epivir) can cause a buildup of lactic acid in the blood (lactic acidosis) and fatty liver. Both conditions can be life-threatening, and you might be more likely to experience them if you're female of larger body size. Make sure to get blood tests done while you take lamivudine (Epivir) so your provider can check your liver health. If you experience signs and symptoms of liver damage, such as upper right stomach pain, yellowing of the skin or whites of the eyes, or dark urine, talk with your provider right away. Also, let your provider know if you experience symptoms of lactic acidosis, such as feeling weak, muscle pain, and trouble breathing.
In some rare cases, children who took lamivudine (Epivir) in clinical studies have reported inflammation of the pancreas (pancreatitis). Some common symptoms of an inflamed pancreas are upper stomach pain, fever, nausea, and vomiting. If your child starts to feel any of these symptoms, contact their provider right away.
Taking lamivudine (Epivir) for HIV can cause changes to your immune system called immune reconstitution syndrome. This medical condition happens when your immune system becomes more active after you start lamivudine (Epivir) treatment. Your immune system begins to fight off different infections that it was too weak to fight off before you started treatment. In rare cases, your immune system might improve so much with treatment that it starts to attack normal cells in your body (autoimmune). You can develop immune reconstitution syndrome as early as during the first few weeks of lamivudine (Epivir) treatment or many months later. Tell your healthcare provider right away if you start having any new symptoms, such as fever, pain, hair loss, bulging eyes, or sweating, after starting lamivudine (Epivir).
In clinical studies, children who take lamivudine (Epivir) oral solution with other antiretroviral oral solutions experience lamivudine (Epivir) not working as well to treat HIV. This is because most oral solutions contain sorbitol, a sweetener that can lead to a lower amount of lamivudine (Epivir) in their body. Because of this effect, consider using lamivudine (Epivir) tablets if your child weighs at least 14 kg (30 pounds). If your child needs to take lamivudine (Epivir) oral solution, their provider will order blood work more often to make sure this medication is working well.
HIV
Epivir, generic oral tablet, generic oral solution
HBV
Epivir HBV, generic oral tablet
Your dose might differ if you have kidney problems.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.